Literature DB >> 18187226

Should patients with type 2 diabetes and raised liver enzymes be referred for further evaluation of liver disease?

Ingrid J Hickman1, Anthony J Russell, Johannes B Prins, Graeme A Macdonald.   

Abstract

Raised liver enzymes are common in type 2 diabetes (T2DM) but often considered benign. Non-alcoholic fatty liver was the cause in 65% of cases but other causes included alcoholic liver disease and viral hepatitis. Cirrhosis was identified in 11 patients. There is a significant burden of advanced liver diseases from a variety of aetiologies in patients with T2DM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18187226     DOI: 10.1016/j.diabres.2007.11.016

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  2 in total

1.  Preliminary in vitro and in vivo evaluation of antidiabetic activity of Ducrosia anethifolia Boiss. and its linear furanocoumarins.

Authors:  Nagwa M M Shalaby; Howaida I Abd-Alla; Hanan F Aly; Marzougah A Albalawy; Kamel H Shaker; Jalloul Bouajila
Journal:  Biomed Res Int       Date:  2014-03-31       Impact factor: 3.411

2.  Metabolic dysfunction-related liver disease as a risk factor for cancer.

Authors:  Alasdair Taylor; Moneeza K Siddiqui; Philip Ambery; Javier Armisen; Benjamin G Challis; Carolina Haefliger; Ewan R Pearson; Alex S F Doney; John F Dillon; Colin N A Palmer
Journal:  BMJ Open Gastroenterol       Date:  2022-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.